MedPath

Role of pulmonary collectins and antimicrobial peptides in patients with pulmonary nontuberculous mycobacteria disease

Not Applicable
Conditions
Pulmonary nontuberculous mycobacterial disease
Registration Number
JPRN-UMIN000027652
Lead Sponsor
Division of Respiratory Medicine, National Hospital Organization Kyoto Medical Center
Brief Summary

The KCQ revealed that the proportion of frail NTM patients at diagnosis was higher than that of frail BE patients (48.5% vs. 22.2%, p = 0.026). HADS scores were significantly higher in the NTM group than in the BE group (p < 0.01). Bronchoalveolar lavage fluid (BALF) hCAP/LL-37 and SP-D levels were significantly higher (p = 0.001), but serum hCAP/LL-37 levels were significantly lower in the NTM group than in the BE group (p = 0.023).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
69
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with HIV infection or disseminated MAC infection, without CRT scan data are excluded. Patients whose observational time is less than 12 months.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath